An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a new Tulane University study.
Researchers may have found a powerful new preventative against the AIDS virus, which has killed more than 40 million people since the epidemic began in 1981.
Final results of the highly anticipated PURPOSE 1 trial of lenacapavir show the shots prevent new infections without many side effects. Medscape Medical News
Three people effectively cured of HIV have spoken about how a risky transplant procedure saved their lives, with one saying they are "living proof" of hope in the fight against the virus.
This study provides new perspectives on transmission of hepatitis C virus (HCV), a virus that infects the liver and can be transmitted during injection of drugs, among men who have sex with men (MSM).
Researchers in George Mason University's Center for Infectious Disease Research (CIDR) and Tulane National Primate Research Center have conducted a breakthrough proof-of-concept study, published in the journal Gene Therapy, that found an...
A behavioral pain self-management intervention is effective for chronic pain in people living with HIV, according to a study published online July 15 in JAMA Internal Medicine.
Long-acting injectable cabotegravir (CAB-LA) was safe and well-tolerated as HIV pre-exposure prophylaxis (PrEP) before and during pregnancy in the follow-up phase of a global study among cisgender women. The analysis of outcomes from...
Current or previous use of the antiretroviral drug (ARV) abacavir was associated with an elevated risk of major adverse cardiovascular events (MACE) in people with HIV, according to an exploratory analysis from a large international...
A single laboratory-based HIV viral load test used by U.S. clinicians who provide people with long-acting, injectable cabotegravir (CAB-LA) HIV pre-exposure prophylaxis (PrEP) did not reliably detect HIV in a multi-country study.
A new "vaccine-like" HIV drug that currently costs over $40,000 per person a year could be made for as little as $40, researchers estimated on Tuesday.
Nearly 40 million people were living with the HIV virus that causes AIDS last year, over 9 million weren't getting any treatment, and the result was that every minute someone died of AIDS-related causes, the U.N. said in a new report...
HIV researchers and activists were killed when a missile hit their passenger airplane over Ukraine 10 years ago in the deadliest shoot-down incident to this day. Medscape Medical News
Gilead could bring the AIDS pandemic towards an end if the US pharmaceutical giant opens up access to its game-changing new HIV drug, the head of UNAIDS told AFP.
Decisions political leaders take this year will be decisive whether a target to end AIDS as a public health threat by 2030 can be reached, the United Nations said Monday.
Your chances of developing long COVID have significantly decreased since the pandemic began, according to a new study published in the New England Journal of Medicine. WebMD Health News
A 60-year-old German man is likely the seventh person to be effectively cured from HIV after receiving a stem cell transplant, doctors announced on Thursday.
Globally, around 2.6 million children and adolescents are currently living with HIV, the majority of them in Africa. These young people are much more likely to experience treatment failure than adults. Experts long assumed that testing...
A research team at Georgia State University has developed tiny, potent molecules that are capable of targeting hidden strains of HIV. The source? Antibody genes from llama DNA.
Now that more people with HIV in South Africa are on antiretroviral therapy (medicines to treat HIV), more are surviving long enough to face the health consequences of tobacco smoking.
An intensive, 12-week pain self-management program has been shown to reduce pain and improve mood in a large clinical trial of people with both HIV and chronic pain. The research, led by University of Pittsburgh physician-scientist...
A study published in Clinical Infectious Diseases led by Massachusetts General Hospital investigators, warns that Tennessee's new HIV prevention funding policy will lead to poorer health outcomes for its residents.
A survey of over half a million people in low- and middle-income countries found that men and women with disabilities were 25% less likely to have comprehensive knowledge about HIV prevention compared to people without disabilities. They...
A comprehensive national effort to improve the uptake of cervical screening among women living with HIV in Uganda resulted in more than 280,000 screening visits in the second year of the campaign, up from just 6500 visits in the first...
The emergence of high-level dolutegravir resistance was extremely rare in people switched to first-line dolutegravir-based treatment in Zambia and Malawi, a large prospective study has found. But the risk of having unsuppressed HIV one...
Baby girls are more likely to acquire HIV from their mothers during pregnancy or childbirth than infant boys, who are conversely more likely to achieve cure or remission, researchers say in a new study that sheds light on the gender...
The majority of people who develop low-level viral load on dolutegravir resuppress viral load without needing to change treatment, a large Nigerian study has found, confirming observations regarding the frequency of viral load...
A mutation that can undermine two-drug treatment with dolutegravir and lamivudine persists for at least 12 years in the ‘archive’ of HIV locked up in the DNA of blood cells in one in three people, French researchers report. Their study...
A multinational team led by Weill Cornell Medicine investigators developed a test that will help measure the persistence of HIV in people affected by viral strains found predominantly in Africa-;a vital tool in the search for an HIV cure...
A major challenge in developing a vaccine for HIV is that the virus mutates fast-;very fast. Although a person initially becomes infected with one or a few HIV strains, the virus replicates and mutates quickly, resulting in a "swarm" of...
A multinational team led by Weill Cornell Medicine investigators developed a test that will help measure the persistence of HIV in people affected by viral strains found predominantly in Africa—a vital tool in the search for an HIV cure...
It's not making major news headlines like in the '80s, but HIV remains a significant health concern. About 38 million people are living with HIV, the virus that causes AIDS, according to the World Health Organization.
Clinical education should teach a broader understanding of respectful clinical care for racialised women living with HIV from low-income backgrounds, an American study finds. While respecting patient autonomy is important, a singular...
The proportion of people with HIV who remain engaged with HIV care has declined over the years since HIV treatment began to be recommended for all people living with HIV, according to a retrospective cohort study published recently in...
A study designed to find out whether it is necessary or even desirable to test and treat gay and bisexual male and trans-female PrEP users for the bacterial STIs chlamydia or gonorrhoea every three months has produced an inconclusive...
In a far-reaching effort to understand the factors contributing to HIV transmission among sexual and gender minority (SGM) individuals and improve HIV prevention strategies, a team of scientists at the CUNY Graduate School of Public...
Four months after seeking asylum in the U.S., Fernando Hermida began coughing and feeling tired. He thought it was a cold. Then sores appeared in his groin and he would soak his bed with sweat. He took a test.
While Chinese gay and bisexual men living with HIV experienced the negative impacts of their intersecting identities – especially when it came to stigma – they also described how their identities enabled them to thrive in ways they...
Just two injections a year of a new HIV drug protected young women in Africa from infection with the sexually transmitted disease, new trial results show.
Metabolic disorders – including excess weight, obesity and diabetes – are significant causes of liver disease among people with HIV in lower and middle-income countries, while hepatitis B and C play a minimal role, a study published in...
A clinical trial has found that medically-tailored meals and groceries, combined with nutritional education, can reduce hospitalisations and improve mental and physical health in people with HIV. However, the intervention did not yield...
A $1.58 million grant will support work by a health communication scholar at the University of Tennessee (UT) Health Science Center's College of Nursing and a medical oncologist at West Cancer Center and Research Institute (WCCRI) to...
Malcolm Reid recently marked the anniversary of his HIV diagnosis on Facebook. "Diagnosed with HIV 28 years ago, AND TODAY I THRIVE," he wrote in a post in April, which garnered dozens of responses.